Premium
Efficacy of switching from adalimumab originator to adalimumab biosimilar in moderate to severe psoriasis patients: A Real‐life experience in a tertiary referral centre
Author(s) -
Gallo Giuseppe,
Rostagno Elisabetta,
Siliquini Niccolò,
Stroppiana Elena,
Verrone Anna,
Ortoncelli Michela,
Quaglino Pietro,
Dapavo Paolo,
Ribero Simone
Publication year - 2021
Publication title -
australasian journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.67
H-Index - 53
eISSN - 1440-0960
pISSN - 0004-8380
DOI - 10.1111/ajd.13632
Subject(s) - adalimumab , dermatology , medicine , section (typography) , psoriasis , university hospital , family medicine , computer science , disease , operating system
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom